Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
36596 POSTS 0 COMMENTS
For men with prostate cancer

Clinician-Referred Exercise Program Beneficial in Prostate CA

0
Clinician referral to a 12-week program ups vigorous exercise levels and improves mental health
Delivery of antioxidants to the eye may be a therapeutic option for cataracts

Review Explores Challenges of Ocular Antioxidants for Cataracts

0
Prospects for future research include the use of nanotechnology to deliver antioxidants
Most patients with atrial fibrillation (AF) and systolic heart failure who undergo ablation have AF recurrence at five years

A-Fib Recurrence Common Five Years After Ablation

0
For patients with a-fib and heart failure, mortality rates lower after ablation versus no ablation
Medical students in personal distress may be more likely to have suboptimal attitudes about self-prescribing and personal responsibility for reporting impaired colleagues

Suboptimal Prescribing Attitudes Could Signal Personal Distress

0
Med students experiencing depression, alcohol abuse less likely to report impaired colleagues
Phenytoin appears to be neuroprotective in acute optic neuritis

AAN: Phenytoin Neuroprotective in Optic Neuritis

0
Adjusted eye retinal nerve fiber layer thickness higher for those receiving phenytoin versus placebo
For patients with Behçet's syndrome

Apremilast Effective for Oral Ulcers in Behçet’s Syndrome

0
Reduction in number of oral ulcers per patient; greater decline in pain from ulcers with apremilast
For clinically atypical pigmented lesions

Review Compares Shave, Punch Biopsy Methods

0
No difference in rate of overall positive margins for all lesions; size, morphology impact positivity
Hydration during primary percutaneous coronary intervention is associated with a reduction in the risk of contrast-induced nephropathy

Hydration During PCI Cuts Risk of Contrast-Induced Nephropathy

0
CIN significantly associated with mortality and need for dialysis; hydration is predictor of CIN
Hydroxychloroquine appears to be associated with lower risk of hyperlipidemia in patients with early rheumatoid arthritis

Hydroxychloroquine May Reduce Hyperlipidemia Risk in Early RA

0
Reduced risk of hyperlipidemia with hydroxychloroquine versus other DMARDs
The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis.

FDA: Generic Copaxone Approved for Multiple Sclerosis

0
FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug